Evidence map›Paper›PMID 42273341›Full record

ArticleSmall science2026

Discovery of Novel Ionizable Lipids for Lipid Nanoparticles: Lipophilicity as a Predictor of Squaramide Head Group Lipid Clearance.

E Sathyajith Kumarasinghe, Edward J Hennessy, Michael W Danneman, Kristine E Burke, Timothy Salerno, Erin E Giardino, Matthew D Crawford, Erin L Thomas, Paulo L Markaj, Farbod Mahmoudinobar and 5 more

Abstract read
In one paragraph

Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

E Sathyajith KumarasingheModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0001-1164-7032
Edward J HennessyModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0002-3431-4396
Michael W DannemanModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0004-2359-3213
Kristine E BurkeModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0002-1334-3921
Timothy SalernoModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0003-7261-8037
Erin E GiardinoModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0005-0615-5294
Matthew D CrawfordModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0003-1503-3657
Erin L ThomasModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0001-7996-2477
Paulo L MarkajModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0001-8215-9805
Farbod MahmoudinobarModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0002-4647-598X
Edward AcostaModerna, Inc. Cambridge Massachusetts USA.
Carla LeiteModerna, Inc. Cambridge Massachusetts USA.
Kerry E BenenatoModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0009-9423-3801
Juneyoung LeeModerna, Inc. Cambridge Massachusetts USA.ORCID https://orcid.org/0009-0007-1072-3033
Mohindra SeepersaudModerna, Inc. Cambridge Massachusetts USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ionizable lipids are a critical component of lipid nanoparticles (LNPs) for messenger RNA (mRNA) delivery, driving cellular uptake, endosomal escape, and tolerability. It is well-known that chemical modifications to ionizable lipids profoundly affect both potency and safety profiles. However, the lack of reliable predictive tools, limited understanding of lipid behavior, and the intrinsic complexity of LNPs remain major challenges in LNP development. Among these, in vivo lipid clearance is a critical yet poorly understood factor influencing long-term safety of mRNA loaded LNPs, particularly with respect to their accumulation. Impaired clearance leading to lipid accumulation can pose safety liabilities and contribute to long-term toxicity. To address this, we investigated lipophilic properties of squaramide head group ionizable lipids with ester linkers as surrogates for in vivo clearance. We demonstrate that lipid clearance can be tuned by chemical modification and is predictable from simple lipophilicity calculation. To our knowledge, this represents the first computationally driven approach predicting lipid properties relevant to both efficacy and long-term safety within the current competitive landscape.

Indexed as

cLogPhepatic clearancelipophilicityprotein expressionsquaramide head group ionizable lipid

Identifiers

PMID42273341
PMCPMC13248833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.